| Financial Year |
March 31 2023 |
| Monetary Funds |
3,720,571,026.28 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
143,540,357.92 |
| Accounts Receivable |
1,303,042,048.61 |
| Advances to Suppliers |
912,513,525.23 |
| Other Receivables |
492,464,396.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,936,883,845.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
342,551,158.51 |
| Total Current Assets |
16,447,471,884.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
47,996,314.61 |
| Investment Properties |
-- |
| Fixed Assetes |
24,535,197,919.39 |
| Under-construction Projects |
3,335,102,719.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
261,093,812.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
137,795,427.92 |
| Other Non-Current Assets |
346,941,363.84 |
| Sub-Total of Non-Current Assets |
31,049,443,120.23 |
| Total Assets |
47,496,915,004.65 |
| Short-Term Loans |
300,224,750.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,073,901,753.24 |
| Accounts Payable |
3,050,151,574.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,758,039.97 |
| Taxes Payable |
49,976,133.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,601,750,356.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,266,732,608.69 |
| Other Current Liabilities |
657,954,329.11 |
| Sub-Total of Current Liabilities |
20,068,636,692.50 |
| Long-term Loans |
1,208,994,995.08 |
| Bonds Payable |
5,329,037,275.02 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,309.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,997,791,521.42 |
| Total Liabilities |
28,066,428,213.92 |
| Paid-In Capital(Or Share Stock) |
4,108,213,229.00 |
| Capital Surplus |
13,272,208,119.02 |
| Surplus Reserve |
1,195,116,522.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-673,035,654.39 |
| Minority Stockholder's Interest |
592,370,931.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,838,115,858.77 |
| Owner's Equity（Stockholder's Equity） |
19,430,486,790.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
47,496,915,004.65 |
